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~"~- -~ Symp~omatis Benefit o f  Calcium Antagonists in CAB 
Is Due to Improvement in Coronary Vssomotion 
Philipp A. Kaufnlann, J0rgen Fdelingsdorf, Otto M. Hess. Cordiology, 
University Hospital, Zurich, 8witzeriand 
Coronary vasomotion plays an impadant role in the regulation of myocar- 
dial peduslon. The effect of calcium antagonists on clinical symptomatology 
(functional ciassitisat!a', according to NYHA) and minimal luminal area (MLA; 
ram2) of *~e ~-~ ~ion was evaluated at rest and dudr~ bicycle exercise 
in 73 paLi~:nts wiL~ co,~nary artery disease. 42 patients served as controls 
{group 1) m~d :~ :eceived intrecoronary nicardipine or diltiazem (group 2). 
ML~, was detol~:~insd bybiplane quantitative comnan/angiography. Patient 
characteristics (~ge, ~:,:~ mass index, lipids, number of vessels diseased, 
mean workload) we:e s;:~:#~r fnbeth groups. 
l com~.-: c,~=,,,~m. ~,
An inverse relationship between NYHA and coronary vasomotion was 
found (r = 0.48, p < 0.005) which is abetished after administration ofcalcium 
antagonists. At the same time exertional angina is improved by the calcium 
blocker (32/42 vs. 8/31 group 1 vs. 2, p < 0.01). 
Conclusions: Calcium blockers improve clinical symptomatology by pre- 
venting exerctse-!nduced Coronary vasoconstriction. Thus, the beneficial ef- 
fect of calcium blockers is not only due to the vasodilatory effect on the 
periphery (loading conditions) 10ut appears to be due to the improvement in 
myocardial perfusion by elimination of stenosis vasoconstriction. 
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~'~- ]  Acute Vitamin C Administrat ion Improves 
Endothelium-Dependent Vesodiistlon in 
Insulin-Dependent Diabetic Patients 
Ferds K. Timimi, Henry H. "ring, Kimberly S. Boles, Mary-Anne Roddy, 
Peter Ganz, Mark A. Creager. Brigham and Women's Hospital, Boston, 
Massachusetts 
Insulin-dependent diabetes mallitus is associated with impaired endothelium- 
dependent vasodilation. Oxygen-darived free radicals may contribute to en- 
dothelial dysfunction by enhancing the degradation of endsthelium-dedved 
nitric oxide. We studied the effect of administration of v~rnin C (VIT C), 
an antioxident, on endothelium-dependent and -independent vasodilalion 
in eight subjects (age = 34:1:7 years) with IDDM and eight age/gender 
matched normal controls (NL). None of the subjects had ¢ardinvescolar dis- 
ease, hypertension, hyperchole~terolemia, or used tobacco. Forearm blood 
flow (FBF) was determined by venous occlusion plethysmography. Metha. 
choline chlonde (MET) and sodium nitroprusside (NIP) were infused via an 
intra-arteflal catheter at 0.3-10.0 mcg/min to assess endothelium-dependent 
and -Independent vssodilation, respectively, prior to and dudng concomitant 
intra-artedal Vff C infusion at 24 rag/rain, in IDDM, the FBF dose response 
curve to MET, but not NIP, was augmented by VR C infusion (p = 0.001). 
The peak FBF response to MET was increased from 15.7 ± 4.9 to 21.6 
5.4 ml/t00 mPmin by VlT C (p = 0.02). In NL, the FBF response to 
MET was not altered by VII" C (p = NS). In conclusion, the anttoxidant VIT 
C improves endothelium-dependent vasodilation in IDDM subjects. These 
findings suggest that o~:ygen-dedved free radicals contribute to impaired 
endothalium-depondent vasodilallon in IDDM, and may have a clinical role 
in modifying the course of vascular disease in these patients. 
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~'~- ]  IS Elevated Blood Pressure Hazard in the a Very 
Old? Insights From the Framingham Study 
William B. Kannol, Ralph B, D'Agostino, Janet Cobb, Halit Silbershalz, 
Boston University School of Medicine, Boston, MA 
Them is the pameption that in the very old (> 75 yrs.) hypertension may 
actually pmtact against mortality resulting in reluctance to treat hypertension 
aggressively in persons of advanced age. The relationship of blood pressure 
level to overall and cardiovascular mortality is examined in Framingham 
Study padicipants over age 75 yrs. free of cardiovascular disease (CVD) 
and also in those with interim CVD. Over the extended padod of follow-up 
them were 65 CV deaths in men and 108 in women in the sample free of CV 
events. 
Average annual incidence per 100: women ages 7594 yrs 
CVD Status Syst BP: 
74--119 120-139 140-159 160-179 180-300 
Free of CVD 9 19 19 32 43 
With CVD 79 49 43 48 62 
In subjects free of CVD there was a continuous graded increase in mortality, 
whereas in those with CVD there was a U-shsped curve of mortality in both 
sexes with a substantial excess mortality below 120 mmHG systolic blood 
pressure. 
Excess mortality reported in the aged with low blood pressure appears 
to be limited to those with CVD and may not be due to low blood pressure 
alone. 
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~ - ]  What Is a Significant Change in Left Ventricuisr 
Mass? An Assessment of  Measurement Variability 
of  Serial LV Mass Determination by 3D 
Echocardiogmphy 
Olakunle O. Aldnboboye, Zhanqing Shen, Pasha S. Gopal, Matthew 
J. Schnellbaecher, Donald L_ King. Columbia University and Mr. Sinai 
Medical Center, New York, NY 
Measurement of LV mass by 2D targeted M-mode echo using ABE criteria 
is a widely used method for assessing regression of LV mass during antihy- 
pertensive therapy. This method has a large test-retast inter-measurement 
vadability. Its reported 95% conho~nce interval for a single replicate mea- 
surement is 59 g (18A% of mean) [Goftdiener JS eta], JACC 1995; 25: 
424-30]. 3D echo has f~en extensively validated as an accurate method 
of LV mass measurement in vitro and in vivo. However, determination of 
its inter-measurement vadability for serial measurements of LV mass has 
not been performed. This study determines the confidence intervals for a 
single replicate measurement for determination of LV mass by 3D echo. 
30 unselected patients underwent wo complete 3D echo examinations in 
sequence by the same experienced observer. Between examinal~ons the 
patient was re-positioned. 8-10 short axis images were obtained using a 
real-time chocardlograph, acoustic spatial ocater, personal computer and 
the line of intersection display for operator guidance. Bouodados were man- 
ually traced and myocardial volume and mass computed. 
Results: 
n LV mass range Mean Measurem't 95% Cl 
Exam 1, Exam 2 Ex. 1,Ex.2 .V~iablrdy 
3D 30 116-435,110--421 ~31 g, 231 g 4% 9.1 g :1:25.8 g
Interpretation: A change of LV mass of _> 25.8 g (11.2% of mean) may be 
considered significant, ie, due in part to true biological change and not to 
measurement variability alone. 
Concius/on: 3D echo confidence intewals are approximately one-half as 
large as those for 2D targeted M-mode echo indicating that 3D echo has a 
signitican~ lower inter-measurement variability than 2D targeted M-mode 
echo. 30 echo is supedor to 2D targeted M-mode echo for assessment of LV 
mass. 
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~Long Acting Calcium Channel Blockers Nifedipine 
GITS and Amiodipine in HypertsnMon ~ Rate of  
Myocardial Infarction 
Robert A. Klonar, George Vetroyee. Good Samaritan Hospital, University of 
Southern California, Los Angeles, CA 
In a case.Conttolled retmspec6ve analysis, Psaty et al re.oi ly repoded an 
increase in the incidence of myocardial infarction (MI) among hypertensive 
patients receiving ca~um channal blcckem (CCB's, 16 MI'St1000 pt-years) 
compared to diuretics or beta blockem (10 Ml's/1000 pt-yeere). However 2 
out of 3 of the CCB's used in the study were short acting CCB's. There is little 
published ata on MI rate with newer once-a-day, long acting, CCB's which 
lack large fluctuations in peak to trough chug concentrations. We examined 
Ptizer's clinical data base for the long-acting CCB amlodipine and nifedipine 
GITS (gastrointestinal therapeutic system) in hypertension studies. For all 
hypertension trials; 
